ATAI
pivotal phase trial designs pivotal study single dose randomization target topline data expected end of pivotal study fixed repeat dose randomization target topline data expected mid compass pathways studies are to deliver by and | ATAI
Company
Deck Type
Sector
Industry
Deck date
February 2023
Slide
17 of 33
Similar slides by ATAI
See diffirences between slides (animation)
Investor Presentation
January 2024
compass pathways is currently conducting a phase pivotal program with topline data expected in summer and mid proceeded by long target | ATAI
Investor Presentation
October 2023
compass pathways is currently conducting a phase pivotal program with topline data expected in summer and mid proceeded by long target | ATAI
Investor Presentation
April 2023
pivotal phase trial designs pivotal study single dose randomization target topline data expected summer pivotal study fixed repeat dose randomization target topline data expected mid compass pathways is currently conducting a program composed of two trials which are to deliver by and | ATAI
Investor Presentation
March 2023
pivotal phase trial designs pivotal study single dose randomization target topline data expected summer pivotal study fixed repeat dose randomization target topline data expected mid compass pathways studies are to deliver by and | ATAI
Related slides by other companies
Petco
Investor Day
March 2022
market opportunity and we are well positioned to continue delivering results double digit companion animals supplies tam merchandise covid weeks total source packaged facts internal estimates for tam premium a notes premium reflects only ale als | Petco
Theravance Biopharma
Investor Conference
November 2022
study design | Theravance Biopharma
Theravance Biopharma
Results
February 2023
targets | Theravance Biopharma
Chimerix
Investor Presentation
August 2023
agonist distinct molecular target and efficacy profile relative to efficacy in preclinical models of advanced cancers tox studies complete potential to advance to partnerships established for early stage clinical trials with brown university and cancer center preclinical studies are ongoing to evaluate additional oncology indications and predictive for for clinical development pancreatic cancer model shows the potential of | Chimerix
Other recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io